In adults with seasonal or perennial allergic rhinitis, is nasal obstruction associated with higher SNOT-22 scores?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nasal Obstruction and SNOT-22 Scores in Allergic Rhinitis

Nasal obstruction is NOT associated with higher SNOT-22 scores in allergic rhinitis patients; in fact, it shows no significant correlation with general health-related quality of life measures.

Key Evidence

The most definitive study directly addressing this question found that nasal obstruction was not at all associated with general health-related quality of life (p = 0.267) in adults with persistent allergic rhinitis 1. This was further confirmed by demonstrating no significant correlation between the Nasal Obstruction Severity Evaluation (NOSE) score and quality of life measures (r = -0.05; p = 0.582) 1.

What Actually Drives High SNOT-22 Scores

Instead of nasal symptoms, the following factors are most strongly associated with elevated SNOT-22 scores in allergic rhinitis patients:

  • Sleep-related symptoms were associated with the greatest decrease in general health-related quality of life and higher SNOT-22 scores 1
  • Otologic symptoms (ear-related complaints) showed the second strongest association with decreased quality of life 1
  • Nasal symptoms were least associated with general health-related quality of life among all symptom categories assessed 1

Clinical Context and Symptom Patterns

While nasal obstruction is indeed a common symptom in allergic rhinitis:

  • Nasal congestion occurs in approximately 94% of allergic rhinitis patients 2
  • Nasal blockage is more characteristic of perennial rhinitis compared to seasonal rhinitis 3
  • Obstruction tends to be more predominant in perennial allergic rhinitis (PAR) compared to seasonal allergic rhinitis (SAR) 4

However, the presence or severity of nasal obstruction does not translate into higher SNOT-22 scores or worse quality of life outcomes 1.

Clinical Implications

When evaluating allergic rhinitis patients with elevated SNOT-22 scores, prioritize assessment of:

  • Sleep disturbances (difficulty falling asleep, waking at night, lack of restful sleep) as these drive quality of life impairment 1
  • Ear symptoms (fullness, pressure, pain, eustachian tube dysfunction) which significantly impact patient-reported outcomes 1
  • Recognize that patients complaining primarily of nasal obstruction may have relatively preserved quality of life despite bothersome symptoms 1

Important Caveat

The SNOT-22, while a validated outcomes tool, is a poor diagnostic instrument for differentiating between patients with and without chronic rhinosinusitis, despite its utility in tracking symptom burden 5. Therefore, use SNOT-22 scores for monitoring treatment response rather than diagnosis 5.

Related Questions

What are the treatment options for seasonal allergies?
In patients with allergic rhinitis, is nasal obstruction the most severe symptom according to the Sinonasal Outcome Test‑22 (SNOT‑22) scores?
Is Loratadine (non-sedating antihistamine) a first-line treatment for allergies in adults?
What is the best course of treatment for a 28-year-old patient with persistent nasal congestion and cough over 3 weeks, currently taking Medrol (methylprednisolone) and Flonase (fluticasone)?
Does 25% silver nitrate improve chronic allergic rhinitis?
What is the first‑line treatment for impetigo, including topical therapy for limited lesions and oral antibiotics for extensive disease, facial or intertriginous involvement, methicillin‑resistant Staphylococcus aureus risk, and for pregnant or lactating patients?
In a patient with hyperlipidemia, diabetes, hypertension, possible vitamin D deficiency taking rosuvastatin (Crestor), cetirizine (Zyrtec), glipizide (Glucotrol), lisinopril (Zestril), dapagliflozin (Farxiga), linagliptin (Tradjenta) and ergocalciferol (vitamin D2), can an elevated ferritin be caused by high vitamin B12 levels?
In patients with allergic rhinitis, is nasal obstruction the most severe symptom according to the Sinonasal Outcome Test‑22 (SNOT‑22) scores?
How common are false‑positive results with HIV screening tests (fourth‑generation antigen/antibody immunoassay)?
What are the contraindications for semaglutide and tirzepatide?
How conclusive are a negative rapid plasma reagin (RPR) performed 41 days after possible exposure and a negative treponemal antibody test performed 49 days after exposure for ruling out active syphilis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.